Visual Prognosis after Explantation of a Corneal Shape-Changing Hydrogel Inlay in Presbyopic Eyes by Moshirfar, Majid et al.
 
 











Visual Prognosis after Explantation of a Corneal Shape-
Changing Hydrogel Inlay in Presbyopic Eyes 
 
Majid Moshirfar 1, 2, 3; Benjamin Buckner 3; David B. Rosen 4; Madeline B. Heiland 4; Yasmyne C. Ronquillo 3;                 
David F. Skanchy 5; Harry Y. Liu 6; Tim Melton 3; Liliana Werner 1; Phillip C. Hoopes Jr 1, 3 
1 John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences, School of Medicine, University of Utah, Salt Lake City, UT, USA 
2 Utah Lions Eye Bank, Murray, UT, USA 
3 Hoopes Durrie Rivera Research Center, Hoopes Vision, Draper, UT, USA 
4 College of Medicine-Phoenix, University of Arizona, Phoenix, AZ, USA 
5 Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, Michigan, USA 
6 Health Science Center, McGovern Medical School, University of Texas, Houston, TX, USA 
 
ABSTRACT 
The purpose of this case series is to report visual outcomes in patients who underwent explantation of the Raindrop® 
hydrogel corneal inlay. Retrospective chart review comprising four cases of explantation of the Raindrop® corneal shape-
changing hydrogel inlay: pre-implantation, pre-explantation, and post-explantation values for uncorrected distance 
visual acuity, uncorrected near visual acuity, and corrected distance visual acuity (CDVA) were measured; keratometric 
and tomographic data were collected using the Pentacam system (Oculus, Inc). Three eyes were explanted for 
progressive haze after implantation that persisted even after removal; one eye was explanted due to poor visual acuity 
with no haze formation. All patients experienced decreased unaided and corrected distance visual acuity. Persistent 
increase in corneal thickness and mean keratometry was noted post-explantation. All four patients regained their 
original near visual acuities, but one patient had persistent one-line loss in CDVA. There are long lasting tomographic 
corneal changes following Raindrop inlay explantation. In addition, persistent increased corneal thickness could be 
related to semi-permanent changes in corneal structure and may account for residual haze experienced by patients. 
After explantation, patients may not return to baseline CDVA. 
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INTRODUCTION
The Raindrop® Near Vision Inlay (ReVision, Inc., Denver, 
CO, USA) received US FDA approval for use in the United 
States on June 29, 2016 after being determined to have 
reasonable safety and efficacy [1]. The Raindrop® inlay is 
a transparent microscopic hydrogel-based corneal inlay 
(2millimeter [mm] diameter, 32micrometer [μm] thick, 
placed between 100-200μm depth) [2] designed to 
create a prolate-shaped cornea to correct near visual 
acuity in the non-dominant eye (Fig. 1). The insertion of 
the inlay into the central corneal stromal bed increases 
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stromal volume, which presses against the anterior 
cornea leading to an increase in central corneal 
curvature. This curvature change increases the refractive 
power of the central cornea by a few diopters, providing 
enhanced near visual acuity in presbyopic patients with 
the goal of improved distance and near visual acuity 
relying on the principle of monovision [2]. This product is 
no longer distributed in the United States after an FDA 
safety warning issued in 2018 due to corneal haze [3, 4].  
One study found that adverse events generally took 
place in one of two periods, with the first occurring in the 
first 3 months postoperatively. Common adverse reports 
during this period were flap-related issues, pressure 
spikes, and inlay exchanges. The second period, from 3 
months through 1 year, concerned mainly issues with 
inlay explants and transitory loss of corrected distance 
visual acuity; a small percentage of patients were 
reported to have central stromal haze during this period 
[5]. In addition, the more recent FDA report suggests that 
haze occurring after one year is a significant reason for 
explantation [4]. The purpose of this study is to highlight 
outcomes of patients who underwent Raindrop 
explantation. Data presented as mean, frequency, and 
percentage. 
METHODS 
This is a retrospective case series of patients who 
underwent Raindrop inlay implantation at our facility 
between December 2016 and April 2017. Inclusion 
criteria for implantation were: age 41-65, manifest 
refractive spherical equivalent + 1.00 to -0.5 diopters (D) 
and ≤ 0.75 D cylindrical refraction, requiring + 1.50 to + 
2.50 D for near vision [6]. Charts of patients who 
underwent explantation between December 2017 and 
April 2019 were reviewed. Information was collected on 
pre-implantation, pre-explantation, and post-
explantation values for uncorrected near visual acuity 
(UNVA), uncorrected distance visual acuity (UDVA), and 
best corrected distance visual acuity (CDVA). 
Keratometric data on central corneal thickness (CCT) and 
mean keratometry (Km) was obtained from the 
Pentacam system (Oculus, Inc. Arlington, WA, USA). 
Approval was obtained from the Hoopes Research 
Committee, and informed consent was signed by each 
patient. All procedures adhered to the tenets of the 
Declaration of Helsinki. 
RESULTS 
Eight patients had Raindrop implantation during the 
study period. Four patients (50%) had subsequent 
explantation. The mean duration of implantation was 1.5 
years (range 1 to 2.5 years) with a mean flap thickness of 
175 μm (range 170-180 μm). The most recent data 
available was, on average, 242 days post-explantation 
(range 8-356 days). All four patients complained of blurry 
vision. Two patients complained of discomfort while the 
inlay was in place; both reported resolution of discomfort 
within weeks of explantation. Three patients complained 
of “seeing shadows” while the inlay was in place. 
Three patients had stromal haze that developed during 
implantation and persisted after explantation (Fig. 2). 
The haze resolved at the 1-year post-explantation follow 
up in two of the patients (duration of inlay implantation 
16 and 17 months, respectively). The third patient with 
persistent haze has not completed a 1-month post-
explantation exam (inlay was in place for 28 months). 
Out of the four eyes, only one patient did not experience 
haze during implantation or after removal; this patient’s 
inlay was in place for 12 months. 
All patients regained or improved in UNVA compared to 
the pre-implantation value (mean increase 1.5 lines, 
Snellen) (Table 1). Uncorrected distance visual acuity 
changes ranged from 0-6 lines lost (mean loss of 4 lines, 
Snellen). Data on CDVA post-explantation was available 
in three out of four patients; one patient had persistent 
one-line loss of CDVA on last follow up (Table 1). No 
hyperopic shifts were recorded at any point during 
implantation. Mean keratometry had a mean increase of 
+ 2.5 D after implantation (Table 2). Manifest refraction 
spherical equivalent (MRSE) on all four patients showed a 
myopic shift before removal with mean decrease of -0.75 
D; there was a persistent myopic shift compared to 
baseline in all three patients that had post-explantation 
MRSE (mean -0.46 D) (Table 3). 
 
 
Figure 1: A: Light microscopy of explanted Raindrop® inlay, explanted 
from case 1 at 20x magnification.  The specimen appears to be quite 
intact. Note that the deposits appear to be mostly related to the 
balanced salt solution as they are also observed on the glass slide 
outside of the area of the device. B: Scanning electron microscopy 
photograph of the inlay, showing the fern-like deposits on its surface. 
 
Central corneal thickness had a mean increase of 27 μm 
after implantation. Keratometric and tomographic data 
was available post-explantation in two patients with a 
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Km increase of + 0.7 D and an increased CCT of 10-16 μm 
compared to pre-implantation (Table 2; Fig. 3). 
Densitometry was done using the Pentacam system on 
patient 1 and showed an increase of 19.9 standard gray 
scale units (GSU) over 13 months of implantation. The 
density decreased by 25.0 GSU 8 months after removal 
(Fig. 4). Upon explantation, the inlay was placed on a 
glass slide and allowed to dry at room temperature. It 
was then forwarded to the Intermountain Ocular 
Research Center (University of Utah) for laboratorial 
analysis. Evaluation under a light microscope (Olympus 
Optical Co., Ltd.) (Fig. 1) showed the presence of deposits 
on the inlay, with a fern-like morphology that appeared 
to correspond to dried salts. 
The specimen (inlay on glass slide) was then coated with 
gold-palladium, and then analyzed under scanning 
electron microscopy (SEM - Quanta 600F, ThermoFisher 
Scientific), coupled with energy dispersive spectroscopy 
(EDS) for elemental analysis of the deposits. The analyses 
were done under high vacuum pressure (approximately 
10-6 torr), at room temperature, and an accelerating 
voltage of approximately 10-15 kV. SEM/EDS confirmed 
that the deposits on the inlay were mostly composed of 
sodium (Na) and chlorine (Cl). 
 
 
Figure 2: Photographs of case 1 taken immediately before (A), 1 day 
after (B), and 1 month after (C) explantation of the Raindrop® corneal 
inlay. Note that the haze appears to be subsiding slightly in the more 
direct lighting conditions but lingers with the tangential illumination. 
The observer may mistakenly believe the inlay is still in place when it 
is in fact explanted and there is only residual haze and fibrosis. 
 
Table 1: Changes in Visual Acuity Pre- and Post-explantation of the Raindrop® Hydrogel Corneal Inlay. 
 UDVA UNVA CDVA 
Patients Pre-inlay Pre-explant Post-explant Pre-inlay Pre-explant Post-explant Pre-inlay Pre-explant Post-explant 
1 20/25 20/300 20/80 20/100 20/40 20/63 20/20 20/40+2 20/25+ 
2 20/20 20/25 20/20- 20/50 20/40 20/50 20/20 20/25+2 20/20- 
3 20/20 20/70-2 20/40+2 20/100 20/50 20/100 20/20 20/25- 20/20 
4 20/20-2 20/50 20/50 20/100 20/80 20/100 20/20 20/40 NA 
Abbreviations: CDVA: corrected distance visual acuity; UDVA: uncorrected distance visual acuity; UNVA: uncorrected near visual acuity; NA: not available; Pre-inlay: before 
implantation of inlay; Pre-explant: before explantation of inlay; Post-explant: after explantation of inlay 
 
 
Table 2: Changes in keratometry and CCT Pre- and Post-explantation of the Raindrop® Hydrogel Corneal Inlay. 
 Pre-Implantation Pre-explantation Post-explantation 
Patients Km(D) CCT (μm) Km(D) CCT (μm) Km(D) CCT (μm) 
1 43 537 45.2 554 43.7 555 
2 45 554 45.2 565 NA NA 
3 43.2 580 48.8 632 43.9 596 
4 42.4 559 44.4 586 NA NA 
Abbreviations: Km: mean keratometry; CCT: central corneal thickness; D: diopter; μm: micrometer; NA: not available 
 
 
Table 3: Changes in manifest refraction Pre- and Post-explantation of the Raindrop® Hydrogel Corneal Inlay 
Patient MRSE (D) Pre-implantation MRSE (D) Pre-explantation MRSE (D) post-explantation Change from baseline 
1 -0.375 -1.75 -1.375 -1 
2 -0.125 -0.25 -0.25 -0.125 
3 +0.75 -0.125 +0.5 -0.25 
4 +0.5 -0.125 NA NA 
Abbreviations: MRSE: manifest refraction spherical equivalent; D: diopter; NA: not-available. 
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Figure 3: PENTACAM data for case 1 of the Raindrop® Hydrogel Corneal Inlay. 
A) shows pre-implantation data, with a Km of 43.0 D and CCT of 537 μm. B) shows pre-explantation data with a Km of 45.2 D and CCT of 554 μm. C) shows 
1-day post-explantation data with a Km of 43.5 and CCT of 578 μm. D) shows 1-month post-explantation data with a Km of 43.7 and CCT of 555 μm. 
Abbreviations: Km: mean keratometry; D: diopter; CCT: Central corneal thickness; μm: micrometer. 
 
 
Figure 4: Densitometry from PENTACAM for case 1 of the Raindrop® Hydrogel Corneal Inlay at various time-points.  
Red arrows point to corneal stromal haze and yellow arrows point to the corresponding densitometry measurement. Densitometry values were as follows: 
30.5 grayscale units (GSU) at 1-month post-implantation; 50.4 GSU at 14-months post-implantation; 29.7 GSU at 2-weeks post-explantation; and 25.0 GSU 
at 8-months post-explantation. Density increases with the duration of implantation. After explantation, density decreases with time. We infer that the 
increase in density correlates with corneal haze.  
DISCUSSION 
The results of this case series highlight reasons for the 
high explantation rate of the Raindrop and visual 
prognosis after removal. There appeared to be no 
changes to the inlay over the course of implantation. 
Haze was a very common problem and was persistent up 
to 1 year after explantation. Tomography and 
keratometry demonstrated corneal shape changes 
induced by the inlay; these changes persisted to some 
degree after explantation. 
Garza et al. reported a case of explantation due to 
unsatisfactory visual outcomes [7]. Chayet et al. reported 
another case of explantation that occurred in a patient 
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that had LASIK post-inlay implantation and experienced 
haze [8]. In the FDA post-approval study for Raindrop, 
there is a 23% explant rate over 5 years [4]. 
Normal density values (for eyes without history of 
corneal inlay) based on densitometry measurements are 
reported to be around 20 GSU [9]. Our data showed an 
increase in density with duration of implantation (Fig. 4). 
We postulate that corneal haze and increased density 
may be secondary to inflammatory changes induced by 
the implant. Both haze and density decreased over 
months after removal. Resolution of haze may occur 
through the cornea’s restorative mechanisms. This 
includes epithelial healing via limbal stem cells, basement 
membrane remodeling, and stromal healing via 
keratocyte motility and Transforming growth factor beta 
(TGF-beta) activation [10]. Densitometry has been used 
to monitor haze in other patients with a corneal inlay 
[11]. We suggest that densitometry is a more objective 
way to measure haze-related changes induced by corneal 
inlays. The long-term recoverability of these impacted 
corneas remains to be seen, and additional studies 
should be conducted to investigate this phenomenon. 
Corneal tomography showed an expected Km increase 
after implantation. However, Km and CCT were 
persistently elevated even after explantation, 
demonstrating that there were residual changes in 
corneal shape. This could explain why two of the patients 
still maintained better UNVA even after inlay removal. 
Despite these changes, all tomographic values trended 
toward baseline on latest follow-up (Table 2; Fig. 3). 
Longer follow up is needed to determine if corneal shape 
will return to baseline after inlay removal. 
As a point of comparison, the KAMRA® inlay also has 
studies on its explantation [12, 13]. A recent study of 
KAMRA® explantation from Shing Ong et al. found that 
one major complication during implantation was corneal 
haze and accompanying hyperopic refractive shifts [12]. 
It was also found that after explantation the vision 
trended back toward baseline values and the authors 
concluded that early removal led to better visual 
outcomes [12]. Haze was a similar reason for 
explantation of the Raindrop, although hyperopic shifts 
were not reported in our series. Both inlays trend toward 
baseline values after removal. However, the method of 
insertion – flap insertion (Raindrop®) and pocket 
insertion (KAMRA®), the insertion depth, and the 
mechanism of action differ significantly between the two 
inlays. 
There were several limitations to this study. First, there 
was a very small sample size. The study was retrospective 
in nature and limited by the amount of information 
available in the chart. Follow up times varied widely, with 
minimal post-explantation data available on one patient. 
Perhaps a larger sample size with more consistent follow 
up could bring greater insight to factors associated with 
development and resolution of haze. If more patients 
had data available on tomography and densitometry, 
more robust conclusions could be made as to the 
changes induced by the Raindrop corneal inlay. 
CONCLUSION 
Despite the small sample size and retrospective nature of 
the study, we conclude that the Raindrop is associated 
with significant adverse effects, the most common being 
blurry vision and stromal haze. Because of the small 
sample size, it is difficult to establish a temporal 
relationship between haze development and resolution. 
Persistent shape changes may account for improvement 
of UNVA after removal, but deficits in UDVA are common 
with potential for persistent loss of CDVA. In addition, 
tomographic and density changes persisted post-
explantation (Figs. 3 and 4). Patients should not expect to 
return to pre-implantation values in the short term after 
removal.  As per FDA advice, patients with Raindrop 
implants should follow-up regularly, even after 
explantation, due to the development of corneal haze 
[4]. Alternative synthetic inlays other than the Raindrop® 
exist [7, 14-20]. However, allogenic implants such as the 
presbyopic allogenic refractive lenticule (PEARL) [21] and 
TransForm corneal allograft (TCA) [22] are undergoing 
clinical trials. Perhaps using an allogenic implant will 
result in a lower complication rate and will not induce as 
visually-disturbing corneal haze as synthetic inlays such 
as the Raindrop. 
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